NASDAQ:FOCL FocalTherics (FOCL) Stock Price, News & Analysis $3.17 -0.07 (-2.16%) As of 04:00 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About FocalTherics Stock (NASDAQ:FOCL) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get FocalTherics alerts:Sign Up Key Stats Today's Range$3.16▼$3.3950-Day Range$3.17▼$4.7452-Week Range$1.95▼$6.40Volume89,447 shsAverage Volume63,363 shsMarket Capitalization$118.97 millionP/E RatioN/ADividend YieldN/APrice Target$9.67Consensus RatingModerate Buy Company Overview EDAP TMS S.A., together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. It operates in three segments: High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution Services (DIST). The HIFU segment develops, manufactures, and markets medical devices based on HIFU technology for the minimally invasive treatment of urological and other clinical indications. This segment also offers Ablatherm, an ultrasound guided robotic HIFU device for the treatment of organ-confined prostate cancer; Ablatherm Fusion that incorporates the company's proprietary fusion software, which merges MRI and ultrasound images; and the Focal One, a HIFU robotic device dedicated to the focal therapy of prostate cancer, as well as disposables, and leasing and treatment related services; and maintenance services. The ESWL division manufactures, markets, and services lithotripter for the treatment of urinary tract stones by means of ESWL technology; and offers Sonolith i-move, an extracorporeal shockwave lithotripter to small and mid-size hospitals, as well as sells disposable parts for lithotripters and electrodes. The Distribution division markets, distributes, and services lasers, micro-ultrasound systems, and other medical products from third parties, as well as leases devices; sells disposables and spare parts; and offers maintenance services. The company markets and sells its products through its direct marketing, sales organization, and service platform, as well as through third-party distributors and agents. Its customers include hospitals, urology clinics, and research institutions. The company was incorporated in 1979 and is headquartered in Lyon, France. Read More FocalTherics Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks51st Percentile Overall ScoreFOCL MarketRank™: 2.56108897742 of 5 starsFocalTherics scored higher than 51% of companies evaluated by MarketBeat, and ranked 530th out of 877 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.7 / 5Analyst RatingModerate Buy Consensus RatingFocalTherics has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 1 strong buy rating, 1 buy rating, 1 hold rating, and 1 sell rating.Upside PotentialFocalTherics has a consensus price target of $9.67, representing about 204.9% upside from its current price of $3.17.Amount of Analyst CoverageFocalTherics has only been the subject of 2 research reports in the past 90 days.Read more about FocalTherics' stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for FocalTherics are expected to grow in the coming year, from ($0.71) to ($0.56) per share.Price to Book Value per Share RatioFocalTherics has a P/B Ratio of 3.30. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted1.08% of the float of FocalTherics has been sold short.Short Interest Ratio / Days to CoverFocalTherics has a short interest ratio ("days to cover") of 9.37.Change versus previous monthShort interest in FocalTherics has recently increased by 9.14%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldFocalTherics does not currently pay a dividend.Dividend GrowthFocalTherics does not have a long track record of dividend growth. News and Social Media2.9 / 5News Sentiment0.66 News SentimentFocalTherics has a news sentiment score of 0.66. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Healthcare companies.News Coverage This WeekMarketBeat has tracked 13 news articles for FocalTherics this week, compared to 3 articles on an average week.MarketBeat Follows5 people have added FocalTherics to their MarketBeat watchlist in the last 30 days. This is an increase of 67% compared to the previous 30 days. Company Ownership1.1 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, FocalTherics insiders have not sold or bought any company stock.Percentage Held by Insiders10.10% of the stock of FocalTherics is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions62.74% of the stock of FocalTherics is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about FocalTherics' insider trading history. Receive FOCL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for FocalTherics and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. FOCL Stock News HeadlinesHC Wainwright Increases Earnings Estimates for FocalThericsNovember 12, 2026 | americanbankingnews.comEDAP TMS S.A. (FOCL) Presents at 2026 UBS Global Healthcare Conference TranscriptNovember 11, 2026 | seekingalpha.comDrop these 5 stocks before the market opens tomorrow!The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratings' latest research says 2026 could be very rough for some well-known stocks. A major shift now taking shape in the market could hit some of America's most-loved names hard. Weiss analysts have pinpointed five stocks they believe investors should steer clear of while it plays out.November 16 at 1:00 AM | Weiss Ratings (Ad)FocalTherics Reports Lower Q3 Loss Of $4 Mln; Shares Drop 21% As Guidance NarrowedNovember 8, 2026 | rttnews.comFocalTherics (NASDAQ:FOCL) Raised to Hold at Wall Street ZenNovember 7, 2026 | americanbankingnews.comEDAP TMS (FOCL) Q3 2026 Earnings Call TranscriptNovember 6, 2026 | finance.yahoo.comFocalTherics™ Reports Third Quarter 2026 Financial ResultsNovember 5, 2026 | finance.yahoo.comFocalTherics™ to Participate in Upcoming Investor ConferencesNovember 4, 2026 | globenewswire.comSee More Headlines FOCL Stock Analysis - Frequently Asked Questions How have FOCL shares performed this year? FocalTherics' stock was trading at $4.65 on June 2, 2026. Since then, FOCL stock has decreased by 31.8% and is now trading at $3.17. How were FocalTherics' earnings last quarter? FocalTherics (NASDAQ:FOCL) released its quarterly earnings data on Thursday, November, 5th. The company reported ($0.10) earnings per share for the quarter, beating analysts' consensus estimates of ($0.18) by $0.08. The firm earned $9.83 million during the quarter. FocalTherics had a negative trailing twelve-month return on equity of 223.32% and a negative net margin of 59.77%. Read the conference call transcript. How do I buy shares of FocalTherics? Shares of FOCL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of FocalTherics own? Based on aggregate information from My MarketBeat watchlists, some other companies that FocalTherics investors own include OPKO Health (OPK), Riot Platforms (RIOT), Solid Biosciences (SLDB), Intel (INTC), MannKind (MNKD), ExxonMobil (XOM) and Plug Power (PLUG). Company Calendar Last Earnings11/05/2026Today11/16/202638th Annual Healthcare Conference12/02/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Yellow Zone (1w+) 1-Year History Nov 25 Feb 26 May 26 Aug 26 Nov 26 For the last 11 days, FOCL's financial health has been in the Yellow zone, according to TradeSmith. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryHealthcare Equipment Current SymbolNASDAQ:FOCL Previous SymbolNASDAQ:EDAP CIK1041934 Webedap-tms.com Phone33672643508Fax33-04-72-15-31-51Employees230Year FoundedN/APrice Target and Rating Average Price Target for FocalTherics$9.67 High Price Target$15.00 Low Price Target$4.00 Potential Upside/Downside+204.9%Consensus RatingModerate Buy Rating Score (0-4)2.50 Research Coverage4 Analysts Profitability EPS (Trailing Twelve Months)($0.98) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$29.25 million Net Margins-59.77% Pretax Margin-59.21% Return on Equity-223.32% Return on Assets-41.32% Debt Debt-to-Equity Ratio0.98 Current Ratio2.63 Quick Ratio2.40 Sales & Book Value Annual Sales$70.53 million Price / Sales1.69 Cash FlowN/A Price / Cash FlowN/A Book Value$0.96 per share Price / Book3.30Miscellaneous Outstanding Shares37,530,000Free Float33,738,000Market Cap$118.97 million OptionableOptionable Beta-0.02 The 7 Best High-Yield Dividend Stocks for 2027Looking for higher dividend income in 2027? Discover seven high-yield dividend stocks with attractive payouts, proven dividend histories and growth potential.Get This Free Report This page (NASDAQ:FOCL) was last updated on 11/16/2026 by MarketBeat.com Staff. From Our PartnersA $247 tool for $7Bill Poulos is offering his $247 Instant Scanner for $7 in the Black Friday sale. It's one payment for a full ...Profits Run | SponsoredWhy I'm selling my Snapback Indicator for just $7For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...Base Camp Trading | SponsoredWhat the hell is going on?Porter Stansberry says President Trump is quietly replacing the U.S. dollar without a vote in Congress, and th...Porter & Company | SponsoredEvery Starlink dish pays this stockThere's a chip inside every Tesla and Starlink dish that Elon doesn't own. He pays royalties to use it. Now...Behind the Markets | SponsoredDrop these 5 stocks before the market opens tomorrow!The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratin...Weiss Ratings | SponsoredYour Copy is on Hold (Claim it now)James Altucher, who called NVIDIA in 2008 and SpaceX years before a single share traded, has a new report on E...Paradigm Press | SponsoredSmall-Cap SMX is Taking its Technology into Multiple Trillion-Dollar Industries!SMX (NASDAQ: SMX) uses proprietary molecular-marking technology and a Digital Material Passport platform to gi...Smallcaps Daily | SponsoredThis Tech Could Be Bigger Than Apple, Amazon, and Microsoft CombinedA breakthrough technology backed by Elon Musk, Sam Altman and Jensen Huang could one day be worth more than Ap...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding FocalTherics Please log in to your account or sign up in order to add this asset to your watchlist. Share FocalTherics With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.